Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment

被引:3
|
作者
Doppler, K. [1 ]
Sommer, C. [1 ]
机构
[1] Univ Klinikum Wurzburg, Neurol Klin & Poliklin, D-97080 Wurzburg, Germany
来源
NERVENARZT | 2013年 / 84卷 / 12期
关键词
Nav1.7; SCN9A mutation; Small fiber neuropathy; Erythromelalgia; polymorphism; SMALL-FIBER NEUROPATHY; CHANNEL ALPHA-SUBUNIT; FAMILIAL ERYTHROMELALGIA; SODIUM-CHANNELS; NA(V)1.7; SCN9A; DISORDER; POLYMORPHISM; ERYTHERMALGIA; SYMPTOMS;
D O I
10.1007/s00115-012-3621-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Voltage-gated sodium channels are essential for electrogenesis in excitable cells. The isoform Nav1.7 is primarily expressed in nociceptors. Mutations of the SCN9A gene, which codes for the alpha-subunit of Nav1.7, are the cause of primary erythromelalgia and paroxysmal extreme pain disorder, two rare neuropathic pain conditions. Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain. These findings not only contribute to the understanding of the pathophysiology of neuropathic pain but also offer targets for a more specific pain therapy.
引用
收藏
页码:1428 / +
页数:6
相关论文
共 50 条
  • [11] Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8
    Nassar, Mohammed A.
    Levato, Alessandra
    Stirling, L. Caroline
    Wood, John N.
    MOLECULAR PAIN, 2005, 1
  • [12] NaV1.7: A central role in pain
    Waxman, Stephen G.
    Dib-Hajj, Sulayman D.
    NEURON, 2023, 111 (17) : 2615 - 2617
  • [13] Upregulation of Nav1.7 by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain
    Tian, Jun-Jie
    Tan, Chao-Yang
    Chen, Qin-Yi
    Zhou, Ying
    Qu, Zu-Wei
    Zhang, Meng
    Ma, Ke-Tao
    Shi, Wen-Yan
    Li, Li
    Si, Jun-Qiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (02) : 782 - 794
  • [14] Familial pain syndromes from mutations of the Nav1.7 sodium channel
    Fischer, Tanya Z.
    Waxman, Stephen G.
    YEAR IN NEUROLOGY 2, 2010, 1184 : 196 - 207
  • [15] Evaluation of Selective NaV1.7 Inhibitors for the Treatment of Ocular Pain
    Delwig, Anton
    Pajouhesh, Hassan
    Yeomans, David
    Du Bois, Justin
    Miljanich, George
    Mulcahy, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [16] Leveraging atropisomerism in the identification of NaV1.7 inhibitors for the treatment of pain
    Milgram, Benjamin
    Chu-Moyer, Margaret
    DiMauro, Erin
    Gao, Hua
    Guzman-Perez, Angel
    La, Daniel
    Marx, Isaac
    Moyer, Bryan
    Boezio, Alessandro
    Butler, John
    Graceffa, Russell
    Kreiman, Charles
    Peterson, Emily
    Sparling, Brian
    Romero, Karina
    Weiss, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [17] Nav1.7, its mutations, and the syndromes that they cause
    Waxman, Stephen G.
    NEUROLOGY, 2007, 69 (06) : 505 - 507
  • [18] Sodium channels Nav1.7, Nav1.8 and pain; two distinct mechanisms for Nav1.7 null analgesia
    Iseppon, Federico
    Kanellopoulos, Alexandros H.
    Tian, Naxi
    Zhou, Jun
    Caan, Gozde
    Chiozzi, Riccardo
    Thalassinos, Konstantinos
    Cubuk, Cankut
    Lewis, Myles J.
    Cox, James J.
    Zhao, Jing
    Woods, Christopher G.
    Wood, John N.
    NEUROBIOLOGY OF PAIN, 2024, 16
  • [19] Discovery of a novel class of benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
    Hoyt, Scott B.
    London, Clare
    Gorin, David
    Wyvratt, Matthew J.
    Fisher, Michael H.
    Abbadie, Catherine
    Felix, John P.
    Garcia, Maria L.
    Li, Xiaohua
    Lyons, Kathryn A.
    McGowan, Erin
    MacIntyre, D. Euan
    Martin, William J.
    Priest, Birgit T.
    Ritter, Amy
    Smith, McHardy M.
    Warren, Vivien A.
    Williams, Brande S.
    Kaczorowski, Gregory J.
    Parsons, William H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4630 - 4634
  • [20] Nav1.7 and Nav1.8: Role in the pathophysiology of pain
    Hameed, Shaila
    MOLECULAR PAIN, 2019, 15